Hundreds of biochemical analyses on a single chip

Scientists at EPFL and the University of Geneva have developed a microfluidic device smaller than a domino that can simultaneously measure up to 768 biomolecular interactions

2012-09-25

(Press-News.org) This press release is available in French.

Inside our cells, molecules are constantly binding and separating from one another. It's this game of constant flux that drives gene expression asides essentially every other biological process.

Understanding the specific details of how these interactions take place is thus crucial to our overall understanding of the fundamental mechanisms of living organisms. There are millions of possible combinations of molecules, however; determining all of them would be a Herculean task. Various tools have been developed to measure the degree of affinity between a strand of DNA and its transcription factor. They provide an indication of the strength of the affinity between them.

"Commercial" devices, however, have one main drawback: many preliminary manipulations are necessary before an experiment can be carried out, and even then, the experiment can only focus on a dozen interactions at a time.

Microns-wide channels As part of his doctoral research at the California Institute of Technology (Caltech), Sebastian Maerkl designed a device that he named "MITOMI" – a small device containing hundreds of microfluidic channels equipped with pneumatic valves. This week Maerkl, who is now an assistant professor in EPFL's Bioengineering Institute, is publishing an article describing the next step in the evolution of the device in Proceedings of the National Academy of Sciences (PNAS). The new version, "k-MITOMI," was developed in the context of the SystemsX.ch RTD DynamiX in cooperation with the University of Geneva.

This microfluidic device has 768 chambers, each one with a valve that allows DNA and transcription factors to interact in a very carefully controlled manner. "In traditional methods, we generally manage to determine if an interaction takes place or not, and then we restart the experiment with another gene or another transcription factor," Maerkl explains. "Our device goes much further, because it allows us to measure the affinity and kinetics of the interaction."

The strength of the device lies in a sort of "push-button" in its microreactors. A protein substrate is immobilized on the device; above it circulates a solution containing DNA moelcules. The push-button is activated at regular intervals of a few milliseconds, trapping protein-DNA complexes that form on the surface of the device. "Then we close the lid, and fluorescence reveals the exact number of bound molecules," explains Maerkl. "We can also observe how long these molecules remain bound."

In addition to providing quantitative kinetic information, the k-MITOMI device can work in a "massively parallel" manner. Each of the 768 independent chambers can simultaneously analyze different molecule pairs. It can also be used to synthesize proteins in vitro, with a massive reduction in time and number of manipulations compared to the traditional method, which involves producing proteins inside a living organism such as a bacterium, purifying, and putting them in contact with the genes to be studied.

"The number of protein-protein and protein-DNA interactions that remain to be characterized is phenomenal. Our device not only allows us to accelerate the acquisition of this information, which is crucial to our understanding of living organisms, but it also meets a need for the production of specific proteins," adds Maerkl.

### END

ELSE PRESS RELEASES FROM THIS DATE:

Boosting natural marijuana-like brain chemicals treats fragile X syndrome symptoms

2012-09-25

Irvine, Calif. — American and European scientists have found that increasing natural marijuana-like chemicals in the brain can help correct behavioral issues related to fragile X syndrome, the most common known genetic cause of autism. The work indicates potential treatments for anxiety and cognitive defects in people with this condition. Results appear online in Nature Communications. Daniele Piomelli of UC Irvine and Olivier Manzoni of INSERM, the French national research agency, led the study, which identified compounds that inhibit enzymes blocking endocannabinoid ...

Making it easier to make stem cells

2012-09-25

LA JOLLA, Calif., September 25, 2012 – The process researchers use to generate induced pluripotent stem cells (iPSCs)—a special type of stem cell that can be made in the lab from any type of adult cell—is time consuming and inefficient. To speed things up, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) turned to kinase inhibitors. These chemical compounds block the activity of kinases, enzymes responsible for many aspects of cellular communication, survival, and growth. As they outline in a paper published September 25 in Nature Communications, ...

Impaired protein degradation causes muscle diseases

2012-09-25

When the "fire brigade" arrives too late Impaired protein degradation causes muscle diseases RUB researchers and international colleagues report in Brain New insights into certain muscle diseases, the filaminopathies, are reported by an international research team led by Dr. Rudolf Andre Kley of the RUB's University Hospital Bergmannsheil in the journal Brain. The scientists from the Neuromuscular Centre Ruhrgebiet (headed by Prof. Matthias Vorgerd) at the Neurological University Clinic (Director: Prof. Martin Tegenthoff) cooperated with colleagues from eleven institutes ...

Palliative care experts call for better home care

2012-09-25

Improved home care resources for people with conditions such as dementia, who would prefer to die at home, are key to providing better end of life care and reducing the strain of the UK's ageing population on the NHS, according to researchers at King's College London. A new study, carried out by researchers from the Cicely Saunders Institute at King's and funded by the National Institute for Health Research Health Services &Delivery Research (NIHR HS&DR) Programme, found that 42 per cent of patients with advanced non-malignant conditions reported a preference for home ...

Dr. Yutaka Niihara: Novel therapy helps ease pain and suffering for sickle cell patients

2012-09-25

LOS ANGELES (Sept. 25, 2012) – Chronic, debilitating pain and potential organ failure are what approximately 100,000 sickle cell patients in the United States live with each day. Yutaka Niihara, M.D., M.P.H. - lead investigator at The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) and co-founder of Emmaus Medical, Inc., an LA BioMed spin-off company - is developing a low-cost, noninvasive treatment that helps provide relief for patients suffering from the debilitating effects of sickle cell disease. Dr. Niihara and his team of investigators ...

Researchers develop new technique for IDing proteins secreted by cells

2012-09-25

Researchers from North Carolina State University have developed a new technique to identify the proteins secreted by a cell. The new approach should help researchers collect precise data on cell biology, which is critical in fields ranging from zoology to cancer research. The work is important because cells communicate by secreting proteins. Some of the proteins act on the cell itself, telling it to grow or multiply, for example. But the proteins can also interact with other cells, influencing them to perform any biological function. Traditionally, scientists who wanted ...

Oscillating microscopic beads could be key to biolab on a chip

2012-09-25

CAMBRIDGE, Mass. -- If you throw a ball underwater, you'll find that the smaller it is, the faster it moves: A larger cross-section greatly increases the water's resistance. Now, a team of MIT researchers has figured out a way to use this basic principle, on a microscopic scale, to carry out biomedical tests that could eventually lead to fast, compact and versatile medical-testing devices. The results, based on work by graduate student Elizabeth Rapoport and assistant professor Geoffrey Beach, of MIT's Department of Materials Science and Engineering (DMSE), are described ...

'The Dust Queen's' research stars in new American Chemical Society video

2012-09-25

WASHINGTON, Sept. 25, 2012 — A new episode in the American Chemical Society's (ACS') popular Prized Science video series features insights into the effects of wind-blown dust on human health and climate from Vicki Grassian, Ph.D. She has jokingly been called "the Dust Queen" and is a noted authority on the tiny particles of sand and dirt, termed mineral dust, that are transported from areas as remote as the Sahara Desert. The video, produced by the ACS, the world's largest scientific society, is available at www.acs.org/PrizedScience and by request on DVD. Prized Science ...

By improving pain treatment, therapy in dogs, research offers medical insight for humans

2012-09-25

MANHATTAN, KAN. -- A Kansas State University professor's research improving post-surgery pain treatment and osteoarthritis therapy in dogs may help develop better ways to treat humans for various medical conditions. From the use of hot and cold packs to new forms of narcotics, James Roush, professor of clinical sciences, is studying ways to lessen pain after surgery and improve care for small animals, particularly dogs. He is working with the clinical patients who come to the College of Veterinary Medicine's Veterinary Health Center. Because humans and dogs experience ...

Grief stages can be likened to pinball machine workings, Baylor University Researcher says

2012-09-25

WACO, Texas (Sept. 25, 2012) — Moving through the traditional stages of grief can be as unpredictable as playing a pinball machine, with triggers of sorrow acting like pinball rudders to send a mourner into a rebound rather than an exit, according to a case study by a Baylor University researcher and a San Antonio psychologist. For some, grieving is complete after the loss is accepted. But for others, such events as the anniversary of a death or a scene that jogs the memory can send them slamming into grief again, according to a case study by Margaret Baier, Ph.D., an ...

LAST 30 PRESS RELEASES:

How stepping into nature affects the brain

Study: Cancer’s clues in the bloodstream reveal the role androgen receptor alterations play in metastatic prostate cancer

FAU Harbor Branch awarded $900,000 for Gulf of America sea-level research

Terminal ileum intubation and biopsy in routine colonoscopy practice

Researchers find important clue to healthy heartbeats

Characteristic genomic and clinicopathologic landscape of DNA polymerase epsilon mutant colorectal adenocarcinomas

Start school later, sleep longer, learn better

Many nations underestimate greenhouse emissions from wastewater systems, but the lapse is fixable

The Lancet: New weight loss pill leads to greater blood sugar control and weight loss for people with diabetes than current oral GLP-1, phase 3 trial finds